Acutaas Chemicals Limited
Acutaas Chemicals Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 15,842 | 68.2 | 15.91 | 0.02 | 3,214.40 |
| Sep 2026 | 15,842 | 68.2 | 15.91 | 0.02 | 3,214.40 |
| Sep 2026 | 15,842 | 68.5 | 15.91 | 0.02 | 3,214.40 |
| Oct 2026 | 15,492 | 68.0 | 15.83 | 0.02 | 3,196.50 |
| Oct 2026 | 15,158 | 67.2 | 15.65 | 0.02 | 3,160.60 |
Acutaas Chemicals Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 3,296,748,000.0 | 4,223,519,000.0 | 3,931,833,000.0 | 2,072,372,000.0 |
| Net Profit | 742,601,000.0 | 1,317,608,000.0 | 1,079,605,000.0 | 442,934,000.0 |
| EPS | 9.1 | — | 13.2 | 5.4 |
Acutaas Chemicals Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 13,289,682,000.0 | 9,999,668,000.0 | 7,130,117,000.0 | 6,130,573,000.0 | — |
| Net Profit | 3,562,553,000.0 | 1,587,136,000.0 | 427,730,000.0 | 832,897,000.0 | — |
| EPS | 43.5 | 19.8 | 5.8 | 11.4 | — |
Acutaas Chemicals Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 19,839,643,000.0 | 15,492,611,000.0 | 10,959,033,000.0 | 7,669,384,000.0 | — |
| Total Liabilities | 2,732,141,000.0 | 2,291,807,000.0 | 4,131,453,000.0 | 1,729,792,000.0 | — |
| Total Equity | 16,535,610,000.0 | 13,096,287,000.0 | 6,739,974,000.0 | 5,939,592,000.0 | — |
Owes vs Owns
Acutaas Chemicals Limited owed ₹0.14 for every ₹1 it owned in Mar 2026, down from ₹0.23 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.14× | 0.15× | 0.38× | 0.23× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Acutaas Chemicals Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
How it's funded — Mar 2026
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 224.8 | 248.9 | 53.3 | 58.7 |
| Receivables | 362.6 | 290.5 | 206.4 | 230.3 |
| Inventory | 231.3 | 179.9 | 156.7 | 119.2 |
| Fixed assets (tangible) | 982.7 | 687.3 | 530.2 | 260.2 |
| Intangible assets | 111.5 | 65.1 | 67.1 | 41.5 |
| Long-term investments | 0.2 | 0.2 | 0.9 | 3.3 |
| Other assets | 70.8 | 77.4 | 81.3 | 53.8 |
| Liabilities & equity | ||||
| Short-term debt | 26.5 | 8.2 | 103.0 | 3.0 |
| Long-term debt | 9.1 | 0.0 | 113.6 | 0.6 |
| Payables | 153.9 | 156.0 | 134.6 | 142.0 |
| Other liabilities | 83.7 | 65.0 | 61.9 | 27.3 |
| Shareholders' equity | 1,710.8 | 1,320.1 | 682.8 | 594.0 |
| Net tangible assets | 1,542.0 | 1,244.6 | 606.9 | 552.5 |
Acutaas Chemicals Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 2,921,736,000.0 | 1,183,427,000.0 | 1,251,697,000.0 | 655,300,000.0 | — |
| Investing Activities | -2,659,430,000.0 | -2,239,432,000.0 | -3,653,935,000.0 | -330,440,000.0 | — |
| Financing Activities | 40,962,000.0 | 2,611,204,000.0 | 2,393,636,000.0 | -122,500,000.0 | — |